Current Hypertension Guidelines and Blood Pressure Targets
The target blood pressure is <130/80 mmHg for most adults with hypertension, with encouragement to achieve <120/80 mmHg in high-risk patients when tolerated. 1
Blood Pressure Targets: A Risk-Stratified Approach
For High-Risk Patients (≥7.5% 10-year CVD risk)
- Primary target: SBP <130 mmHg (Class I, Level A evidence)
- Preferred target: SBP <120 mmHg when feasible (Class I, Level A evidence) 1
- DBP target: <80 mmHg (Class I, Level B-R evidence) 1
The 2025 AHA/ACC guidelines represent the most recent and authoritative U.S. recommendations, using the race-free PREVENT equations with a 7.5% 10-year risk threshold to define high-risk status 1, 2. This is a significant update that expands intensive treatment eligibility, particularly among younger adults (30-60 years) and those with obesity 3.
For Lower-Risk Patients (<7.5% 10-year CVD risk)
- Target: SBP <130 mmHg may be reasonable (Class IIb, Level B-NR)
- Preferred: SBP <120 mmHg may be considered (Class IIb, Level B-NR)
- DBP target: <80 mmHg may be reasonable (Class IIb, Level B-NR) 1
The evidence is less robust for lower-risk patients, but the guidelines lean toward tighter control to prevent BP progression.
International Consensus: The 130/80 mmHg Standard
The 2024 ESC guidelines and 2020 ISH guidelines align closely with this approach:
- ESC 2024: Target BP <130/80 mmHg, with consideration for 120-129 mmHg in specific populations 4
- ISH 2020: Target BP <130/80 mmHg for evidence-based standards of care 5
This represents a global convergence toward lower BP targets, supported by landmark trials including SPRINT, STEP, BPROAD, and ESPRIT 6.
Special Population Targets
Diabetes
- Target SBP: 130 mmHg and <130 mmHg if tolerated, but not <120 mmHg
- Elderly with diabetes (≥65 years): 130-139 mmHg 4
Chronic Kidney Disease
- Moderate-to-severe CKD (eGFR >30 mL/min/1.73 m²): 120-129 mmHg if tolerated
- General CKD target: 130-139 mmHg
- Individualize for lower eGFR or transplant recipients 4
Stroke/TIA History
- Target: 120-130 mmHg in patients with confirmed BP ≥130/80 mmHg 4
Elderly and Frail Patients
Diagnostic Thresholds
Hypertension is diagnosed at office BP ≥140/90 mmHg, confirmed by:
- Home BP ≥135/85 mmHg, OR
- 24-hour ambulatory BP ≥130/80 mmHg 5
The guidelines emphasize out-of-office BP monitoring for both diagnosis and treatment titration 7.
Treatment Initiation Algorithm
Grade 1 Hypertension (140-159/90-99 mmHg)
- Start lifestyle interventions immediately
- Start drug treatment immediately if:
- High-risk (CVD, CKD, diabetes, organ damage, or age 50-80 years)
- Start drug treatment after 3-6 months of lifestyle intervention if:
- Low-moderate risk with persistent BP elevation 5
Grade 2 Hypertension (≥160/100 mmHg)
- Start drug treatment immediately along with lifestyle interventions 5
- Consider initial combination therapy, preferably single-pill combinations 1
Key Implementation Points
Critical caveat: The real-world BP control rate remains unsatisfactory despite clear evidence. Among U.S. adults currently treated for hypertension, 59.8% (34.6 million) do not meet the <130/80 mmHg target 3. An additional 17.6% are newly eligible for intensification under the <120/80 mmHg preferred target 3.
Common pitfall: Avoid relying solely on office BP measurements. The 2025 guidelines strongly emphasize home BP monitoring using the 722 protocol (duplicate readings, twice daily, over 7 consecutive days) for more accurate assessment and treatment guidance 8.
Monitoring timeline: Achieve target BP within 3 months of treatment initiation 5.
The shift toward <130/80 mmHg represents strong evidence from multiple international trials showing reduced cardiovascular events, total mortality, and even cognitive decline with intensive BP control 1, 6, 7. The challenge is no longer identifying effective treatments but delivering accurate measurement, timely intensification, and sustained follow-up at scale 2.